Updated from 1:47 p.m. EDT Shares of DJ Orthopedics ( DJO) were among the worst-performing health and pharmaceutical stocks Wednesday after the company reported in-line third-quarter financial results but warned that fourth-quarter sales would fall short of expectations. Excluding items, the medical device company posted a profit of 21 cents a share on sales of $63.2 million. Analysts polled by Thomson First Call had expected it to earn 21 cents a share on sales of $63.7 million. Looking ahead, it expects to post fourth-quarter sales of $63.5 million to $65.5 million, reflecting a business transition that will pressure gross margins and sales from its Regentek division. Analysts were looking for sales of $66.4 million. Shares of DJ Orthopedics traded down $1.65, or 8.6%, to $17.45. Applied Biosystems ( ABI) rose after it posted stronger-than-expected fourth-quarter financial results and said that first-quarter earnings would be flat to slightly up vs. the year-ago period. Excluding items, the life sciences company earned 27 cents a share during the fourth quarter on sales of $460.5 million. Analysts had expected it to earn 25 cents a share on sales of $457.4 million. Looking ahead, it said that first-quarter earnings would be equal to or slightly above last year's first-quarter results of 16 cents a share. Analysts were looking for it to earn 18 cents a share. Shares of Applied Biosystems traded up 85 cents, or 4.4%, to $20.20. Shares of Bentley Pharmaceuticals ( BNT) fell after the company reported weaker-than-expected second-quarter financial results. The specialty pharmaceutical company earned 7 cents a share on sales of $18.5 million. Analysts had expected it to earn 8 cents a share on sales of $19.3 million. Looking ahead, it reiterated its full-year sales outlook of $70 million to $80 million. Analysts are looking for it to post sales of $78.7 million. Shares of Bentley Pharmaceuticals traded down $1.38, or 11.1%, to $11.02.